Go Back
Phosphorylations for 'MDM2'
| Source | Sequence | Kinase Gene | Detection Level | Kinase Description | Reference | Experiment type |
|---|---|---|---|---|---|---|
| S 17 (9,7,4) | ||||||
| TDGAVTTSQIPASEQ | ||||||
| S 23 (5,6,1,3,2,8) | ||||||
| TDGAVTTSQIPASEQ | ||||||
| S 70 (9) | ||||||
| GDWLDQDSVSDQFSV | ||||||
| S 72 (9) | ||||||
| WLDQDSVSDQFSVEF | ||||||
| S 76 (9) | ||||||
| DSVSDQFSVEFEVES | ||||||
| S 83 (9) | ||||||
| SVEFEVESLDSEDYS | ||||||
| S 86 (9) | ||||||
| FEVESLDSEDYSLSE | ||||||
| S 90 (9) | ||||||
| SLDSEDYSLSEEGQE | CSNK2A1 | casein kinase 2, alpha 1 polypeptide | ||||
| SLDSEDYSLSEEGQE | PLK1 | polo-like kinase 1 | ||||
| S 92 (9) | ||||||
| DSEDYSLSEEGQELS | ||||||
| T 107 (6) | ||||||
| KEFEREETQDKEESV | ||||||
| S 113 (6) | ||||||
| ETQDKEESVESSLPL | ||||||
| S 117 (6) | ||||||
| KEESVESSLPLNAIE | ATM | ataxia telangiectasia mutated | ||||
| S 137 (8) | ||||||
| RQRKRHKSDSISLSF | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ||||
| RQRKRHKSDSISLSF | DAPK3 | death-associated protein kinase 3 | ||||
| RQRKRHKSDSISLSF | PIM1 | pim-1 oncogene | ||||
| S 139 (8) | ||||||
| RKRHKSDSISLSFDE | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ||||
| S 157 (7) | ||||||
| SHLVSRPSTSSRRRA | MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | ||||
| S 163 (1,2) | ||||||
| SHLVSRPSTSSRRRA | MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | ||||
| S 166 (7) | ||||||
| SSRRRAISETEENSD | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ||||
| SSRRRAISETEENSD | DAPK3 | death-associated protein kinase 3 | ||||
| SSRRRAISETEENSD | PIM1 | pim-1 oncogene | ||||
| SSRRRAISETEENSD | MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | ||||
| VSRPSTSSRRRAISE | ||||||
| VSRPSTSSRRRAISE | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ||||
| S 172 (1) | ||||||
| SSRRRAISETEENSD | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ||||
| SSRRRAISETEENSD | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ||||
| SSRRRAISETEENSD | DAPK3 | death-associated protein kinase 3 | ||||
| SSRRRAISETEENSD | PIM1 | pim-1 oncogene | ||||
| SSRRRAISETEENSD | MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | ||||
| SSRRRAISETEETQD | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ||||
| S 183 (2) | ||||||
| ETQDKEESVESSLPL | ||||||
| S 186 (7) | ||||||
| RQRKRHKSDSISLSF | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ||||
| RQRKRHKSDSISLSF | DAPK3 | death-associated protein kinase 3 | ||||
| RQRKRHKSDSISLSF | PIM1 | pim-1 oncogene | ||||
| S 187 (2) | ||||||
| KEESVESSLPLNAIE | ATM | ataxia telangiectasia mutated | ||||
| S 188 (7) | ||||||
| RKRHKSDSISLSFDE | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ||||
| S 190 (9) | ||||||
| DDKITQASQSQESED | ATM | ataxia telangiectasia mutated | ||||
| S 191 (8) | ||||||
| GDWLDQDSVSDQFSV | ||||||
| S 192 (1) | ||||||
| RQRKRHKSDSISLSF | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ||||
| RQRKRHKSDSISLSF | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ||||
| RQRKRHKSDSISLSF | DAPK3 | death-associated protein kinase 3 | ||||
| RQRKRHKSDSISLSF | PIM1 | pim-1 oncogene | ||||
| S 193 (8) | ||||||
| WLDQDSVSDQFSVEF | ||||||
| S 194 (1) | ||||||
| RKRHKSDSISLSFDE | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ||||
| S 197 (8) | ||||||
| DSVSDQFSVEFEVES | ||||||
| Y 198 (9) | ||||||
| QSQESEDYSQPSTSS | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | ||||
| S 199 (9) | ||||||
| SQESEDYSQPSTSSS | ATM | ataxia telangiectasia mutated | ||||
| S 204 (8) | ||||||
| SVEFEVESLDSEDYS | ||||||
| S 207 (8) | ||||||
| FEVESLDSEDYSLSE | ||||||
| Y 209 (9) | ||||||
| STSSSIIYSSQEDVK | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | ||||
| S 211 (8) | ||||||
| SLDSEDYSLSEEGQE | CSNK2A1 | casein kinase 2, alpha 1 polypeptide | ||||
| SLDSEDYSLSEEGQE | PLK1 | polo-like kinase 1 | ||||
| SSSIIYSSQEDVKEF | ATR | ataxia telangiectasia and Rad3 related | ||||
| S 213 (8) | ||||||
| DSEDYSLSEEGQELS | ||||||
| S 220 (8) | ||||||
| SEEGQELSDEDDEVY | CSNK2A1 | casein kinase 2, alpha 1 polypeptide | ||||
| T 223 (9) | ||||||
| KEFEREETQDKEESV | ||||||
| Y 227 (8) | ||||||
| SDEDDEVYQVTVYQA | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | ||||
| S 229 (9) | ||||||
| ETQDKEESVESSLPL | ||||||
| S 233 (9) | ||||||
| KEESVESSLPLNAIE | ATM | ataxia telangiectasia mutated | ||||
| S 246 (1) | ||||||
| GDWLDQDSVSDQFSV | ||||||
| S 248 (1) | ||||||
| WLDQDSVSDQFSVEF | ||||||
| S 252 (1) | ||||||
| DSVSDQFSVEFEVES | ||||||
| S 259 (1) | ||||||
| SVEFEVESLDSEDYS | ||||||
| S 262 (1) | ||||||
| FEVESLDSEDYSLSE | ||||||
| S 266 (1) | ||||||
| SLDSEDYSLSEEGQE | CSNK2A1 | casein kinase 2, alpha 1 polypeptide | ||||
| SLDSEDYSLSEEGQE | PLK1 | polo-like kinase 1 | ||||
| S 268 (1) | ||||||
| DSEDYSLSEEGQELS | ||||||
| S 275 (1) | ||||||
| SEEGQELSDEDDEVY | CSNK2A1 | casein kinase 2, alpha 1 polypeptide | ||||
| Y 282 (1) | ||||||
| SDEDDEVYQVTVYQA | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | ||||
| S 337 (8) | ||||||
| DDKITQASQSQESED | ATM | ataxia telangiectasia mutated | ||||
| S 339 (7) | ||||||
| DDKITQASQSQESED | ATM | ataxia telangiectasia mutated | ||||
| Y 345 (8) | ||||||
| QSQESEDYSQPSTSS | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | ||||
| S 346 (8) | ||||||
| SQESEDYSQPSTSSS | ATM | ataxia telangiectasia mutated | ||||
| Y 347 (7) | ||||||
| QSQESEDYSQPSTSS | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | ||||
| S 348 (7) | ||||||
| SQESEDYSQPSTSSS | ATM | ataxia telangiectasia mutated | ||||
| Y 356 (8) | ||||||
| STSSSIIYSSQEDVK | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | ||||
| S 358 (8) | ||||||
| SSSIIYSSQEDVKEF | ATR | ataxia telangiectasia and Rad3 related | ||||
| Y 358 (7) | ||||||
| STSSSIIYSSQEDVK | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | ||||
| S 360 (7) | ||||||
| SSSIIYSSQEDVKEF | ATR | ataxia telangiectasia and Rad3 related | ||||
| T 370 (8) | ||||||
| KEFEREETQDKEESV | ||||||
| T 372 (7) | ||||||
| KEFEREETQDKEESV | ||||||
| S 376 (8) | ||||||
| ETQDKEESVESSLPL | ||||||
| S 378 (7) | ||||||
| ETQDKEESVESSLPL | ||||||
| S 380 (8) | ||||||
| KEESVESSLPLNAIE | ATM | ataxia telangiectasia mutated | ||||
| S 382 (7) | ||||||
| KEESVESSLPLNAIE | ATM | ataxia telangiectasia mutated | ||||
| S 392 (1) | ||||||
| DDKITQASQSQESED | ATM | ataxia telangiectasia mutated | ||||
| Y 400 (1) | ||||||
| QSQESEDYSQPSTSS | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | ||||
| QSQESEDYSQPSTSS | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | ||||
| S 401 (1) | ||||||
| SQESEDYSQPSTSSS | ATM | ataxia telangiectasia mutated | ||||
| SQESEDYSQPSTSSS | ATM | ataxia telangiectasia mutated | ||||
| Y 411 (1) | ||||||
| STSSSIIYSSQEDVK | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | ||||
| S 413 (1) | ||||||
| SSSIIYSSQEDVKEF | ATR | ataxia telangiectasia and Rad3 related | ||||
| T 425 (1) | ||||||
| KEFEREETQDKEESV | ||||||
| S 431 (1) | ||||||
| ETQDKEESVESSLPL | ||||||
| S 435 (1) | ||||||
| KEESVESSLPLNAIE | ATM | ataxia telangiectasia mutated |